Loading provider…
Loading provider…
Ophthalmology Physician in Houston, TX
NPI: 1215922406Primary Practice Location
HOUSTON METHODIST HOSPITAL
6565 Fannin St, Houston, TX
Primary Employer
Houston Eye Associates
houstoneye.com
HQ Phone
Get M.D. John's Phone Numberphone_androidMobile
Get M.D. John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1983 - 2025
SC State Medical License
1981 - 1989
OK State Medical License
1985 - 1988
LA State Medical License
1980 - 1985

American Board of Ophthalmology
Ophthalmology
Louisiana State University School of Medicine (New Orleans)
Residency • Ophthalmology
1983 - 1984
Medical University of South Carolina (MUSC)
medicine.musc.edu
Medical School
Until 1979
University of Texas Health Science Center at Houston
Residency • Ophthalmology
1980 - 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 794 | 823 |
| 2 | 92012Eye and medical examination for diagnosis and treatment, established patient | 471 | 913 |
| 3 | 92025Computerized mapping of corneal curvature | 228 | 298 |
| 4 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 188 | 188 |
| 5 | 92286Microscopic evaluation of deep cells of the eye | 188 | 203 |
One year follow-up of epikeratoplasty for myopia.
Authors: Goosey, J D, Prager, T C, Goosey, C B, Martin, D I
Journal: J Cataract Refract Surg
Singlet oxygen as a possible factor in human senile nuclear cataract development.
Authors: Zigler, J S, Goosey, J D
Journal: Curr Eye Res
Nosocomial exacerbation of Fuchs' endothelial dystrophy.
Authors: Mosteller, M W, Goosey, J D, Kaufman, H E
Journal: Am J Ophthalmol
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension